![]() |
||
![]() |
Professor Azim Surani CBE FRS FMedSci Genetic and epigenetic regulators of the germ line and pluripotency Azim is the Mary Marshall and Arthur Walton Professor of Physiology and Reproduction, and a member of the Physiology Department |
|
Co-workers: |
||
We aim to elucidate the genetic programme that regulates specification of mouse primordial germ cells (PGCs), which includes active repression of the somatic programme adopted by the neighbouring cells. We discovered that the transcriptional repressor, Blimp1/Prdm1, is the key regulator of PGC specification. We are exploring the role of this and other key genes involved in PGC specification. Furthermore, Blimp1 forms a novel complex with Prmt5 arginine methylase that is apparently critical for the specification and maintenance of early PGCs, while PRMT5 itself is independently implicated in regulating pluripotency in stem cells, which underlines the relationship between germ cells and pluripotent stem cells.
Following PGC specification, extensive epigenetic reprogramming of the genome follows, which is an essential first step towards the eventual generation of totipotency. In particular, when PGCs migrate into developing gonads at E11.5, they undergo extensive epigenetic modifications, including genome-wide DNA demethylation, erasure of imprints and reactivation of the X chromosome. Dedifferentiation of PGCs into pluripotent EG cells also results in a similar epigenetic reprogramming event following the loss of Blimp1 (Fig 4). We are investigating the mechanism, including the identity of intrinsic factors involved in the epigenetic reprogramming of PGCs, together with the nature of the external signals that trigger it. Our broader objectives are to develop model systems that will attempt to mimic the key aspects PGC specification and epigenetic reprogramming in vitro. The key factors and mechanisms that govern erasure of epigenetic information in PGCs could be relevant for investigations of genomic reprogramming of somatic cells towards pluripotency in vitro. This knowledge could also contribute to advances in human medicine, including the causes of cancers, as well as for the repair and rejuvenation of somatic tissues.
|
Plain English:
Selected publications: • Surani MA, Durcova-Hills G, Hajkova P, Hayashi K and Tee WW (2009) Germ line, stem cells and epigenetic reprogramming. Cold Spring Harb Symp Quant Biol [in press] • Hayashi K, Lopes SM, Tang F and Surani MA (2008) Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Cell 3, 391-401 • Hajkova P, Ancelin K, Waldman T, Lacoste N, Lange UC, Cesari F, Lee C, Almouzni G, Schneider R and Surani MA (2008) Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature 452, 877-881 • Surani MA, Hayashi K, and Hajkova P (2007) Genetic and epigenetic regulators of pluripotency. Cell 128, 747-762 • Hayashi K, de Sousa Lopes SM, Surani MA (2007) Germ cell specification in mice. Science 316, 394-396
|
|
|
Page updated: 10 April 2009 by ad327 The Wellcome Trust/Cancer Research UK Gurdon Institute, |
||